IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

MARFELLA, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 260
AS - Asia 187
NA - Nord America 185
AF - Africa 98
SA - Sud America 12
Totale 742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 176
SG - Singapore 150
RU - Federazione Russa 131
CI - Costa d'Avorio 96
IE - Irlanda 22
HK - Hong Kong 19
DE - Germania 18
IT - Italia 16
FI - Finlandia 15
CZ - Repubblica Ceca 10
CN - Cina 9
UA - Ucraina 9
AT - Austria 8
BR - Brasile 8
ES - Italia 8
NL - Olanda 8
CA - Canada 6
GB - Regno Unito 5
BE - Belgio 2
EG - Egitto 2
LT - Lituania 2
PE - Perù 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BN - Brunei Darussalam 1
BZ - Belize 1
DK - Danimarca 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PL - Polonia 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 742
Salva come PNG Salva come JPEG
Città #
Abidjan 96
Singapore 67
Boardman 26
Dublin 22
Hong Kong 19
Dallas 18
Helsinki 10
Jacksonville 10
Brno 8
New York 8
Amsterdam 7
Chandler 7
Falkenstein 7
Los Angeles 7
Moscow 7
Acerra 5
Córdoba 5
Lappeenranta 5
London 4
Nuremberg 4
Ottawa 4
Frankfurt am Main 3
Vienna 3
Wilmington 3
Bari 2
Brussels 2
Huelva 2
Lima 2
Lisbon 2
Molise 2
Munich 2
Princeton 2
Rome 2
San Mateo 2
Toronto 2
West Jordan 2
Aracaju 1
Arapongas 1
Ashgabat 1
Bandar Seri Begawan 1
Buenos Aires 1
Cairo 1
Caracas 1
Casavatore 1
Caxias do Sul 1
Copenhagen 1
Council Bluffs 1
Dubai 1
Dūmā 1
Fort Wayne 1
Fort Worth 1
Huntsville 1
Jacinto 1
Jinan 1
Kunming 1
Lanzhou 1
Londrina 1
Mexico City 1
Milan 1
Murcia 1
Norwalk 1
Nova Crixás 1
Olomouc 1
Prague 1
Prineville 1
Riga 1
San Francisco 1
Sertânia 1
Shenzhen 1
São João do Ivaí 1
Taipei 1
Tashkent 1
The Dalles 1
Vientiane 1
Washington 1
Yerevan 1
Totale 419
Salva come PNG Salva come JPEG
Nome #
ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial 61
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 47
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 29
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 25
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 23
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 20
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 19
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 19
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 19
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 19
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 18
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 18
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 17
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 17
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 17
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 16
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 16
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 16
Advances in Nanomedicine for Precision Insulin Delivery 16
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 15
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 14
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 14
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 14
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 14
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 13
Metformin: An old drug against old age and associated morbidities 13
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 13
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 12
Cardiovascular benefits from gliflozins: Effects on endothelial function 12
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients 12
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 11
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 10
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 10
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 9
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 9
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia 9
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 9
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 9
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 9
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 9
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 8
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 8
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 8
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up 8
Metformin Lactic Acidosis: should we still be afraid? 8
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 7
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 7
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 7
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review 7
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 7
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 6
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 6
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 5
MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo 3
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity 2
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 2
Role of subcutaneous abdominal fat on cardiac function and proinflammatory cytokines in premenopausal obese women 2
Totale 773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202113 0 1 1 2 4 0 2 0 1 0 2 0
2021/202210 0 2 0 0 0 0 2 1 1 2 0 2
2022/202347 5 1 0 3 2 2 0 3 25 1 5 0
2023/202493 3 2 2 2 4 15 3 7 1 5 5 44
2024/2025596 130 48 95 11 139 13 22 49 88 1 0 0
Totale 773